Search

Por primera vez, un fármaco dirigido está mostrando resultados prometedores en el tratamiento del cáncer pulmonar de células no pequeñas causado por una mutación llamada KRAS-G12D.

… Sunday, April 27, 2025 Durante décadas, los casos de cáncer con mutaciones en el gen  KRAS  se consideraron “no tratables con fármacos”. Las mutaciones en KRAS  se encuentran presentes en más del 20 % de los casos de cáncer. Son más comunes en el  cáncer pulmonar ,  el cáncer de páncreas y el  cáncer

The collective efforts of the “TeamLabs” will accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers

… Tuesday, April 19, 2022 Today, one year after its founding, Break Through Cancer has awarded Memorial Sloan Kettering Cancer Center (MSK) more than $12 million in grants to intercept cancer at the earliest stages and find cures to several of the deadliest cancers. This funding is part of a total of $50

Two important clinical trials to increase treatment options for mantle cell lymphoma patients are currently recruiting patients.

… Friday, August 14, 2020 In a biologically-related B-cell Non-Hodgkin lymphoma/leukemia called chronic lymphocytic leukemia (CLL), it is well-established that novel biologically-targeted therapies are more effective than standard chemotherapy in patients with TP53 mutation or deletion. Based on this previous

Learn how MSK doctors deliver intense doses of radiation with great precision using MRI guidance.

… Tuesday, September 12, 2023 An experimental prostate cancer treatment uses MRI to target radiation and intensify the dose to the tumor — and at the same time reduce side effects.     It’s more precise because MSK radiation oncologists take multiple MRI images during the procedure to adjust for tumor

Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer. She also made huge strides in reducing the stigma surrounding the disease.

… Tuesday, January 9, 2018 On Christmas Eve, Memorial Sloan Kettering and the wider cancer community lost a beloved and brilliant doctor, Jimmie Holland, who died of cardiovascular disease at 89. Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.

… Monday, September 24, 2018 Summary MSK is improving the lives of people with brain cancer and helping their often stressed-out families. Two of MSK’s top brain cancer experts reflect on how they care for people and recent advances in treatment. There are few diseases as feared — or as challenging to

Meet Christine Iacobuzio-Donahue, a physician-scientist who studies cancer metastasis and is collaborating on genetics research with scientists at the American Museum of Natural History.

… Wednesday, November 29, 2017 Physician-scientist Christine Iacobuzio-Donahue is Interim Director of MSK’s David M. Rubenstein Center for Pancreatic Cancer Research . She studies cancer metastasis and is collaborating on genetics research with scientists at the American Museum of Natural History. You

Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.

… Thursday, April 1, 2021 Americans have a love-hate relationship with sugar. Our favorite foods are full of it, yet nutritionists warn that sugar provides empty calories — good for putting on weight but not much else. Cancer doctors are concerned, too, since obesity is a major risk factor for cancer.

Find out how regular screenings with CT scans can help many people who smoke.

… Tuesday, November 10, 2020 Update: On March 9, 2021, the US Preventive Services Task Force (USPSTF) issued new recommendations to expand screening for lung cancer in people who have a history of smoking but no symptoms of the disease. Under the new guidelines, screening is recommended to begin five years

… Wednesday, May 11, 2022 Barbara (“Barb”) Pemberton has a huge smile, an infectious laugh, and a great memory – she vividly remembers how scared she felt when she interviewed to be a phlebotomist in 2004. As she entered the building for the first time, on her way to “stick” someone to demonstrate her